Cargando…

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition

Detalles Bibliográficos
Autores principales:	Pinton, Giulia, Wang, Zhuo, Balzano, Cecilia, Missaglia, Sara, Tavian, Daniela, Boldorini, Renzo, Fennell, Dean A., Griffin, Martin, Moro, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727403/ https://www.ncbi.nlm.nih.gov/pubmed/36505807 http://dx.doi.org/10.3389/fonc.2022.1081632

Ejemplares similares

CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition
por: Pinton, Giulia, et al.
Publicado: (2021)

Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma
por: Al Khatib, MHD Ouis, et al.
Publicado: (2023)

Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia
por: Zonca, Sara, et al.
Publicado: (2017)

Inhibition of the Histone Methyltransferase EZH2 Enhances Protumor Monocyte Recruitment in Human Mesothelioma Spheroids
por: Mola, Silvia, et al.
Publicado: (2021)

Unsymmetric Cisplatin-Based Pt(IV) Conjugates Containing a PARP-1 Inhibitor Pharmacophore Tested on Malignant Pleural Mesothelioma Cell Lines
por: Gabano, Elisabetta, et al.
Publicado: (2021)

SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells
por: Pinton, Giulia, et al.
Publicado: (2016)

Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma
por: Pinton, Giulia, et al.
Publicado: (2017)

Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review
por: Pinton, Giulia, et al.
Publicado: (2021)

Ezh2 Regulates Activation-Induced CD8(+) T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression
por: Chen, Guobing, et al.
Publicado: (2018)

Clinical and genetic characterization of a Chanarin Dorfman Syndrome patient born to diseased parents
por: Durdu, Murat, et al.
Publicado: (2018)

Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency
por: Missaglia, Sara, et al.
Publicado: (2018)

Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition
por: Ayinde, Oluseyi, et al.
Publicado: (2019)

EZH2 Is Essential for Fate Determination in the Mammalian Isthmic Area
por: Wever, Iris, et al.
Publicado: (2019)

Frequent homozygous deletion of Cdkn2a/2b in tremolite‐induced malignant mesothelioma in rats
por: Okazaki, Yasumasa, et al.
Publicado: (2020)

Coordination of EZH2 and SOX2 specifies human neural fate decision
por: Zhao, Yuan, et al.
Publicado: (2021)

EZH2 as a Regulator of CD8+ T Cell Fate and Function
por: Stairiker, Christopher J., et al.
Publicado: (2020)

NLRP1 polymorphisms in patients with asbestos-associated mesothelioma
por: Girardelli, Martina, et al.
Publicado: (2012)

A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings
por: Eskiocak, Ali Haydar, et al.
Publicado: (2019)

Corrigendum: Regulation of T Cell Differentiation and Function by EZH2
por: Karantanos, Theodoros, et al.
Publicado: (2016)

FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma
por: Chung, Catherine T-S, et al.
Publicado: (2010)

Dynamic regulation of EZH2 from HPSc to hepatocyte-like cell fate
por: Pistoni, Mariaelena, et al.
Publicado: (2017)

Precision Therapy for Mesothelioma: Feasibility and New Opportunities
por: Dulloo, Sean, et al.
Publicado: (2021)

Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice
por: Badhai, Jitendra, et al.
Publicado: (2020)

Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma
por: Pinton, Giulia, et al.
Publicado: (2012)

PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression
por: Yang, Liu, et al.
Publicado: (2021)

Mesothelioma: Hippo pathway as a target, lessons from COMMAND
por: Fennell, Dean A., et al.
Publicado: (2019)

CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
por: Kettunen, Eeva, et al.
Publicado: (2019)

Antagonistic interaction between Ezh2 and Arid1a coordinates root patterning and development via Cdkn2a in mouse molars
por: Jing, Junjun, et al.
Publicado: (2019)

LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2
por: Guo, Mengjun, et al.
Publicado: (2022)

Neutral lipid storage disease with myopathy: A 10-year follow-up case report
por: Missaglia, Sara, et al.
Publicado: (2022)

PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1
por: Pinton, Giulia, et al.
Publicado: (2013)

CDKN1C‐mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib
por: Kagiyama, Yuki, et al.
Publicado: (2021)

Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity
por: Pinton, Giulia, et al.
Publicado: (2014)

CDKN1C (p57(KIP2)) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells
por: Yang, Xiaojing, et al.
Publicado: (2009)

EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop
por: Béguelin, Wendy, et al.
Publicado: (2017)

Losses of Both Products of the Cdkn2a/Arf Locus Contribute to Asbestos-Induced Mesothelioma Development and Cooperate to Accelerate Tumorigenesis
por: Altomare, Deborah A., et al.
Publicado: (2011)

Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells
por: Manente, Arcangela G., et al.
Publicado: (2015)

Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
por: Harber, James, et al.
Publicado: (2021)

Correction: CDKN1C (p57(KIP2)) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells
por: Yang, Xiaojing, et al.
Publicado: (2009)

Coordinated Sumoylation and Ubiquitination Modulate EGF Induced EGR1 Expression and Stability
por: Manente, Arcangela Gabriella, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_n5vmr33lq7ovma23qv9nhu1huj